Literature DB >> 4301381

Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.

A Gyselen, L Verbist, J Cosemans, L M Lacquet, E Vandenbergh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4301381     DOI: 10.1164/arrd.1968.98.6.933

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  11 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

Review 2.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

Review 3.  Pulmonary tuberculosis: evolution of modern therapy.

Authors:  M B Rosenblatt
Journal:  Bull N Y Acad Med       Date:  1973-03

Review 4.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

Review 5.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

6.  Chemotherapy of drug-resistant tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1969-08-30

Review 7.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 8.  Rifampin.

Authors:  M Schonell; E Dorken; S Grzybowski
Journal:  Can Med Assoc J       Date:  1972-04-08       Impact factor: 8.262

9.  Rifampin in the treatment of pulmonary tuberculosis.

Authors:  L Hyde
Journal:  Calif Med       Date:  1972-12

10.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.

Authors:  K D Stottmeier; G P Kubica; C L Woodley
Journal:  Appl Microbiol       Date:  1969-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.